Elucidata is a pioneering life sciences MLOps company for the future that transforms biological discovery by integrating different forms of biomedical data. They support discovery programs at Pfizer, Bristol Myers Squibb, Genentech, Stanford and Yale and have 35+ research partners from premier biopharma companies and research labs. They are a 150+ multi-disciplinary team of experts based across the US, Canada, and India. In September 2022, they raised $16 million in their Series A round led by Eight Roads and F-Prime along with their old investors Hyperplane and IvyCap.
“I am extremely impressed by the PollyTM platform that Elucidata has built and the power it has to digest, integrate and analyze large data sets. The unique partnership that we have allows us to work hand-in-hand with the software engineers, scientists, and program managers to rapidly develop novel hypotheses that we can test in the lab. In just a short period of time, we have made significant progress that has had a substantial impact on our growth.”
Read Elucidata Reviews, Testimonials & Customer References from 2 real Elucidata customers.
Browse Elucidata Case Studies, Customer Success Stories, & Customer References from 7 businesses that use Elucidata.